[HTML][HTML] Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

L Gao, Y Zhang, K Sterling, W Song - Translational Neurodegeneration, 2022 - Springer
Synaptic abnormalities are a cardinal feature of Alzheimer’s disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …

[HTML][HTML] Amyloid β-based therapy for Alzheimer's disease: Challenges, successes and future

Y Zhang, H Chen, R Li, K Sterling… - Signal transduction and …, 2023 - nature.com
Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer’s disease (AD),
and its accumulation has been considered as the molecular driver of Alzheimer’s …

Raised serum levels of tumour necrosis factor in parasitic infections

P Scuderi, KS Lam, KJ Ryan, E Petersen, KE Sterling… - The Lancet, 1986 - Elsevier
In a study of serum levels of endogenous tumour necrosis factor (TNF) in healthy people
and patients with neoplastic or infectious disease, only patients with kala-azar (visceral …

A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism …

…, MR Jaff, K Ouriel, TC Engelhardt, KM Sterling… - Cardiovascular …, 2015 - jacc.org
Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the
safety and efficacy of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis, using the …

Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects

…, SH Ingbar, K Sterling - The Journal of clinical …, 1970 - Am Soc Clin Investig
… Analyses for the concentration of stable T3 in serum were carried out by the method of
Sterling, … Sterling, K. 1958. Radiothyroxine turnover studies in thyroid disease after therapy. …

The immunoregulatory function of vitamin D: implications in chronic kidney disease

KA Sterling, P Eftekhari, M Girndt, PL Kimmel… - Nature Reviews …, 2012 - nature.com
Cardiovascular and infectious diseases remain the most common causes of death among
patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Basic …

A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial

VF Tapson, K Sterling, N Jones, M Elder… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives : The aim of this study was to determine the lowest optimal tissue plasminogen
activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed …

[PDF][PDF] The tagging of red cells and plasma proteins with radioactive chromium

SJ Gray, K Sterling - The Journal of Clinical Investigation, 1950 - Am Soc Clin Investig
… It disintegrates by K capture with transmutation to vanadium and emission of Xrays of 4.92
… M., and Sterling, K., The colorimetric determination of trace amounts of chromium in tissues. …

Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia

…, A van Breda, MJ Sheridan, KM Sterling… - Journal of Vascular and …, 2014 - Elsevier
Purpose To report early findings from a prospective United States clinical trial to evaluate the
efficacy and safety of prostatic artery embolization (PAE) for benign prostatic hyperplasia (…

Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience

…, R Raabe, K Hagspiel, JF Benenati, K Sterling… - Journal of Vascular and …, 2008 - Elsevier
PURPOSE: To evaluate the success of lysis and clinical outcomes in patients treated with
ultrasound (US)–accelerated thrombolysis for deep vein thrombosis (DVT). MATERIALS AND …